(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ALINIQ

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ALINIQ

ST13

US500000086506138

Classe

9

Pedido

86506138

Registro

5891457

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

58

Atualização mais recente

31/01/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9

Data de depósito

16/01/2015

Data de registro

22/10/2019

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/01/2026

Última transação

31/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

702

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

31/03/2016

Primeiro uso no comércio

31/03/2016

Código do desenho

4

Tipo de titular

03

Localização do titular

Abbott Park, IL

Examinador

ROACH, APRIL K

Localização atual

Historical data usage

Titulares e representantes

Titulares

A. L. (pessoa física)

Representantes

Michele H. Bowman ABBOTT LABORATORIES

Classificação técnica

Classes Nice

Classe 9

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

computer software for hematology analyzersclinical chemistry analyzersimmunoassay analyzersblood screening instrumentsinstruments for bloodbodily fluid and tissue testing for use in the field of medical diagnostics and software for use in laboratory management; computer software for use in laboratory information management; computer software for data analysis for use in laboratories; computer software for medical diagnostic instruments; computer software supporting medical diagnostic instruments; computer software for hematology analyzersclinical chemistry analyzersimmunoassay analyzersblood screening instrumentsinstruments for bloodbodily fluid and tissue testing; computer software for configuring medical diagnostic instruments; computer software supporting hematology analyzersclinical chemistry analyzersimmunoassay analyzersblood screening instrumentsinstruments for bloodbodily fluid and tissue testing; computer software for configuring medical diagnostic instruments; computer software for configuring hematology analyzersclinical chemistry analyzersimmunoassay analyzersblood screening instrumentsbloodbodily fluid and tissue testing systems; computer software for monitoring medical diagnostic instruments; computer software for monitoring hematology analyzersclinical chemistry analyzersimmunoassay analyzersblood screening instrumentsbloodbodily fluid and tissue testing systems; electronic data interfacing software for medical diagnostic instruments; electronic data interfacing software for hematology analyzersclinical chemistry analyzersimmunoassay analyzersblood screening instrumentsbloodbodily fluid and tissue testing systems; computer software for managing interface between medical diagnostic instruments; computer software for managing interface between laboratory instruments; computer software for troubleshooting regarding medical diagnostic instruments; computer software for troubleshooting regarding laboratory instruments; computer software for processing diagnostic medical testing data; computer software for processing diagnostic laboratory data; computer software for use in medical diagnostic testing

Publicações

Histórico de despachos e eventos da marca no USPTO.

58 publicações encontradas

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

30/01/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

30/01/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

26/01/2026

E815

TEAS SECTION 8 & 15 RECEIVED

22/10/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

22/10/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/05/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

27/05/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

27/05/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

27/05/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

22/10/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

20/09/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

19/09/2019

DMCC

DATA MODIFICATION COMPLETED

18/09/2019

ALIE

ASSIGNED TO LIE

16/09/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/09/2019

IUAF

USE AMENDMENT FILED

02/08/2019

EISU

TEAS STATEMENT OF USE RECEIVED

02/08/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/02/2019

EX5G

SOU EXTENSION 5 GRANTED

06/02/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/02/2019

EXT5

SOU EXTENSION 5 FILED

01/02/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/02/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/08/2018

EX4G

SOU EXTENSION 4 GRANTED

02/08/2018

EXT4

SOU EXTENSION 4 FILED

02/08/2018

EEXT

SOU TEAS EXTENSION RECEIVED

02/08/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/02/2018

EX3G

SOU EXTENSION 3 GRANTED

01/02/2018

EXT3

SOU EXTENSION 3 FILED

01/02/2018

EEXT

SOU TEAS EXTENSION RECEIVED

01/02/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/08/2017

EX2G

SOU EXTENSION 2 GRANTED

01/08/2017

EXT2

SOU EXTENSION 2 FILED

01/08/2017

EEXT

SOU TEAS EXTENSION RECEIVED

01/08/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/02/2017

EX1G

SOU EXTENSION 1 GRANTED

01/02/2017

EXT1

SOU EXTENSION 1 FILED

01/02/2017

EEXT

SOU TEAS EXTENSION RECEIVED

01/02/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/08/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/06/2016

PUBO

PUBLISHED FOR OPPOSITION

07/06/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

18/05/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

30/04/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

29/04/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/04/2016

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

29/04/2016

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

29/10/2015

GNFR

FINAL REFUSAL E-MAILED

29/10/2015

CNFR

FINAL REFUSAL WRITTEN

29/10/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/10/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/10/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/10/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

22/04/2015

GNRT

NON-FINAL ACTION E-MAILED

22/04/2015

CNRT

NON-FINAL ACTION WRITTEN

22/04/2015

DOCK

ASSIGNED TO EXAMINER

21/04/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

29/01/2015

NWAP

NEW APPLICATION ENTERED

20/01/2015

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ALINIQ ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.